| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Role of LAG-3 in regulatory T cells. | Immunity | 2004 | 4.36 |
| 2 | Retracted Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity. | Cancer Res | 2004 | 1.26 |
| 3 | B7-h2 is a costimulatory ligand for CD28 in human. | Immunity | 2011 | 1.17 |
| 4 | Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. | Cancer Res | 2002 | 1.09 |
| 5 | Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease. | J Clin Invest | 2002 | 1.07 |
| 6 | Reassessment of CD62L as a marker of pre-effector T cells in the tumor draining lymph nodes of head and neck cancer patients. | Otolaryngol Head Neck Surg | 2002 | 0.75 |